Tweet
<img alt="" height="1" width="1" />
FDA Okays Xarelto for Stroke Prevention
MedPage Today
The FDA has approved rivaroxaban (Xarelto) for prevention of stroke in patients with nonvalvular atrial fibrillation, making it the first oral direct factor Xa inhibitor to be approved for stroke ...
FDA Approves New Blood Thinner for Irregular HeartbeatFox News
FDA Approves Rivaroxaban for Stroke Prevention in AFForbes
FDA approves rivaroxaban for stroke prevention in AF patientsTheHeart.Org
all 87 news articles »
More...